AAPL

232.1

+0.15%↑

NVDA

137.06

+1.12%↑

MSFT

416.71

+0.17%↑

TSM

205.69

+9.79%↑

ORCL

175.53

+0.46%↑

AAPL

232.1

+0.15%↑

NVDA

137.06

+1.12%↑

MSFT

416.71

+0.17%↑

TSM

205.69

+9.79%↑

ORCL

175.53

+0.46%↑

AAPL

232.1

+0.15%↑

NVDA

137.06

+1.12%↑

MSFT

416.71

+0.17%↑

TSM

205.69

+9.79%↑

ORCL

175.53

+0.46%↑

AAPL

232.1

+0.15%↑

NVDA

137.06

+1.12%↑

MSFT

416.71

+0.17%↑

TSM

205.69

+9.79%↑

ORCL

175.53

+0.46%↑

AAPL

232.1

+0.15%↑

NVDA

137.06

+1.12%↑

MSFT

416.71

+0.17%↑

TSM

205.69

+9.79%↑

ORCL

175.53

+0.46%↑

Начало・Списък с акции・Azenta Inc

Azenta Inc

Затворен

Сектор Технологични

43.42 -1.23

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

43.41

Максимум

44.7

Ключови измерители
By Trading Economics
Приходи	130M -6.6M
Продажби	14M 173M
EPS	0.16
Марж на печалбата	-3.805
EBITDA	11M 10M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+35.29 upside

Дивиденти
By Dow Jones
Следващи печалби	11.11.2024 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-105M 2.5B
Предишно отваряне	44.65
Предишно затваряне	43.42

Настроения в новините

By Acuity

50%

163 / 384 Класиране в Technology

Azenta Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

16.10.2024 г., 23:50 ч. UTC

Горещи акции

Stocks to Watch: Tesla, CSX, Alcoa

16.10.2024 г., 23:30 ч. UTC

Придобивния, сливания и поглъщания

Discover Financial, SEC Working to Resolve Misclassification Matter -- Update

16.10.2024 г., 20:35 ч. UTC

Печалби

CSX Posts Higher Revenue, Profit in 3Q on Increased Volume

16.10.2024 г., 23:59 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

16.10.2024 г., 23:59 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Woodside's LNG Deal Edges Ammonia Play, Bull Says -- Market Talk

16.10.2024 г., 23:53 ч. UTC

Пазарно говорене

Gold Steady Ahead of Key U.S. Economic Data -- Market Talk

16.10.2024 г., 23:50 ч. UTC

Пазарно говорене

Santos's Pikka Cost Rise Expected, But Builds Debt Pain -- Market Talk

16.10.2024 г., 22:46 ч. UTC

Топ новини

RTX Agrees to More Than $950 Million in Penalties to Settle Qatar Bribery, Contract Fraud Charges -- 2nd Update

16.10.2024 г., 22:33 ч. UTC

Топ новини

RTX Agrees to More Than $950 Million in Penalties to Settle Qatar Bribery, Contract Fraud Charges -- Update

16.10.2024 г., 22:18 ч. UTC

Топ новини

Elon Musk Taps Longtime Aide to Oversee Tesla's Operations in North America, Europe, Sources Say -- WSJ

16.10.2024 г., 21:32 ч. UTC

Печалби

Morgan Stanley's Bumper Earnings Power Stock to Record High -- Barrons.com

16.10.2024 г., 21:20 ч. UTC

Топ новини

China Security Group Urges Review of Intel's Chips as Tech Tension With U.S. Rises -- 2nd Update

16.10.2024 г., 20:50 ч. UTC

Пазарно говорене

Financial Services Roundup: Market Talk

16.10.2024 г., 20:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Health Care Roundup: Market Talk

16.10.2024 г., 20:16 ч. UTC

Топ новини

Dow Edges Up; Morgan Stanley Gains on Strong Earnings Headline -- WSJ

16.10.2024 г., 20:12 ч. UTC

Печалби

Kinder Morgan Cites Lower Than Budgeted Commodity Prices and Start-Up Delays on RNG Facilities >KMI

16.10.2024 г., 20:11 ч. UTC

Печалби

Kinder Morgan Expects Adj EBITDA to Be Up 5% and Adj EPS to Be Up 9% for FY Vs 2023 >KMI

16.10.2024 г., 20:11 ч. UTC

Печалби

Kinder Morgan Now Expects to Be Below Budget on Adj EBITDA by About 2% and on Adj EPS by About 4% >KMI

16.10.2024 г., 20:10 ч. UTC

Печалби

Kinder Morgan Expects to Declare Dividends of $1.15 Per Shr for 2024 >KMI

16.10.2024 г., 20:10 ч. UTC

Печалби

Kinder Morgan Budgeted 2024 DCF of $5 B, or $2.26 Per Share >KMI

16.10.2024 г., 20:10 ч. UTC

Печалби

Kinder Morgan Project Backlog at End of 3Q Was $5.1 B >KMI

16.10.2024 г., 20:07 ч. UTC

Печалби

Kinder Morgan: Final Investment Decision Reached for Gulf Coast Express Pipeline Expansion >KMI

16.10.2024 г., 20:06 ч. UTC

Печалби

CSX Corp: 4Q Volume Expected to Grow Modestly>CSX

16.10.2024 г., 20:05 ч. UTC

Печалби

CSX Corp: Lower revenue, Storm Impacts May Reduce Sequential Operating Margin in 4Q, Limiting 2H Margin Growth >CSX

16.10.2024 г., 20:05 ч. UTC

Печалби

Kinder Morgan 3Q Rev $3.7B >KMI

16.10.2024 г., 20:05 ч. UTC

Печалби

Kinder Morgan 3Q Adj EPS 25c >KMI

16.10.2024 г., 20:05 ч. UTC

Печалби

Kinder Morgan 3Q EPS 28c >KMI

16.10.2024 г., 20:05 ч. UTC

Печалби

Kinder Morgan 3Q Net $625M >KMI

16.10.2024 г., 20:05 ч. UTC

Печалби

Kinder Morgan Sees FY EPS $1.22 >KMI

16.10.2024 г., 20:05 ч. UTC

Печалби

Kinder Morgan Sees FY Net $2.7B >KMI

Сравнение с други в отрасъла

Ценова промяна

Azenta Inc Прогноза

Ценова цел

By TipRanks

35.29% нагоре

12-месечна прогноза

Среден 59.5 USD 35.29%

Висок 69 USD

Нисък 50 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Azenta Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Azenta Inc през последните 3 месеца.

Настроение

By Acuity

163 / 384 Класиране в Технологични

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Azenta Inc

Brooks Automation, Inc. is a provider of semiconductor manufacturing automation solutions and life science sample-based services. The Company operates in three reportable segments: the Brooks Semiconductor Solutions Group segment, the Brooks Life Sciences Products segment and the Brooks Life Sciences Services segment. The Brooks Semiconductor Solutions Group segment provides a variety of products, services and solutions, such as atmospheric and vacuum robots, robotic modules, tool automation systems, contamination control of carrier pods and reticle storage. The Brooks Life Sciences Products segment provides automated cold sample management systems for compound and biological sample storage, equipment for sample preparation and handling, consumables and instruments. The Brooks Life Sciences Services segment provides a range of sample management programs, integrated cold chain solutions, informatics, as well as sample-based laboratory services.